Baricitinib for the Prophylaxis of Graft-Versus-Host Disease After Peripheral Blood Hematopoietic Cell Transplantation

Clinical trial NCT04131738 · COMPLETED

Trial details

NCT number: NCT04131738
Sponsor: Washington University School of Medicine
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Graft-versus-host-disease Graft Vs Host Disease

Start date: 2020-04-07
Primary completion: 2021-11-30
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.